Genprex
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3300 Bee Caves Rd Ste 650-227, Austin, T...Phone Number
(877) 774-4679Website
www.genprex.comRevenue
-Stock Symbol
GNPXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Genprex
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel trea...Explore more
Genprex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genprex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Genprex is spiking on competitors!
Check if Genprex has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Genprex launches new products
Genprex, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Genprex
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Genprex has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Genprex had a recent Job posting/layoffs
Earning: See what the market has to say on Genprex recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Genprex
Compare insights from companies similar to Genprex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Genprex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genprex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genprex.
Genprex financials insights
Gather financial insights about Genprex, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$25.5M
2023
Share Placement
$7.5M
Genprex Tech Stack
A closer look at the technologies used by Genprex
Most Recent Scoops
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Partnership
Project
Partnership, Product Development, Product Management, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals, Clinical Operations
Earnings
Manufacturing Operations, Operations
Earnings
Financial Planning, Clinical Operations, Operations
Genprex News & Media
Genprex to Participate at BIO International Convention 2026
The BIO International Convention Brings Together More Than 20,000 Biotech Industry Leaders From Around The World AUSTIN, Texas, June 17, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing...Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
Trop-2 H-scores Above 100 and PTEN H-scores Below 100 Correlated With Longer Progression Free Survival in Non-Small Cell Lung Cancer Patients Identified Biomarkers May Predict Patient Response, Enable Targeted Patient Selection and Allow for Precision Medicine AUSTIN, Texas, May 26, 2026...Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
Strengthens Patent Estate and Expands Protection in Another Target Market AUSTIN, Texas, April 30, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer...Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
Pdx1/MafA Gene Therapy Reversed Hyperglycemia in Type 2 Diabetic Models Within Four Weeks AUSTIN, Texas, April 28, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genprex
Sign Up For FreeTo access detailed company insights
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex wor... Read More
